These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1694250)

  • 1. Multi-drug resistance of a doxorubicin-resistant bladder cancer cell line.
    Floyd JW; Lin CW; Prout GR
    J Urol; 1990 Jul; 144(1):169-71. PubMed ID: 1694250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a doxorubicin-resistant human bladder cancer cell line (MGH-U1R).
    McGovern F; Kachel T; Vijan S; Schiff S; Lin CW; Prout GR
    J Urol; 1988 Aug; 140(2):410-4. PubMed ID: 3398164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of verapamil on a multi-drug resistant bladder carcinoma cell line and its potential as an intravesical chemotherapeutic agent.
    Long JP; Prout GR; Wong YK; Lin CW
    J Urol; 1990 May; 143(5):1053-6. PubMed ID: 2329596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative cytotoxicities of adriamycin and epirubicin in combination with lonidamine against human bladder cancer cell lines.
    Popert RJ; Masters JR; Coptcoat M; Zupi G
    Urol Res; 1995; 22(6):367-72. PubMed ID: 7740656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM.
    Kimiya K; Naito S; Soejima T; Sakamoto N; Kotoh S; Kumazawa J; Tsuruo T
    J Urol; 1992 Aug; 148(2 Pt 1):441-5. PubMed ID: 1353119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the potential of transferrin-adriamycin conjugates in the treatment of bladder cancer.
    Munns J; Yaxley J; Coomer J; Lavin MF; Gardiner RA; Watters D
    Br J Urol; 1998 Aug; 82(2):284-9. PubMed ID: 9722768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a multidrug-resistant human bladder carcinoma cell line RT112/D21.
    Seemann O; Muscheck M; Siegsmund M; Pilch H; Nebe CT; Rassweiler J; Alken P
    Urol Res; 1995; 22(6):353-60. PubMed ID: 7740654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multiple drug resistance in human bladder cancer cell lines.
    Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB
    J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
    Guo H; Lu G; Xiong X; Dong J; Liu S
    Chin Med J (Engl); 1997 Mar; 110(3):167-72. PubMed ID: 9594332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
    Erlichman C; Vidgen D
    Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of CA19-9 as a tumor marker in urothelial malignancy.
    Chuang CK; Liao SK
    Scand J Urol Nephrol; 2004; 38(5):359-65. PubMed ID: 15764245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
    Knuchel R; Hofstadter F; Jenkins WE; Masters JR
    Cancer Res; 1989 Mar; 49(6):1397-401. PubMed ID: 2493980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells.
    Gosland MP; Lum BL; Sikic BI
    Cancer Res; 1989 Dec; 49(24 Pt 1):6901-5. PubMed ID: 2582432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-lapse live cell imaging and flow analysis of multidrug resistance reversal by verapamil in bladder cancer cell lines.
    Featherstone JM; Lwaleed BA; Speers AG; Hayes MC; Birch BR; Cooper AJ
    Urology; 2009 Aug; 74(2):378-84. PubMed ID: 19501884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemosensitivity in established human bladder carcinoma and HELA cell lines in vitro].
    Uchibayashi T
    Nihon Hinyokika Gakkai Zasshi; 1983 Sep; 74(9):1606-20. PubMed ID: 6202921
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
    Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
    Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The activity of etoposide (VP16) in combination chemotherapy against human bladder cancer cells in vitro].
    Hattori T; Satoh M; Terashima Y; Nishimura T; Akimoto M
    Hinyokika Kiyo; 1991 Sep; 37(9):995-8. PubMed ID: 1785427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
    Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM
    J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy of bladder cancer cell lines.
    Datta SN; Allman R; Loh CS; Mason M; Matthews PN
    Br J Urol; 1997 Sep; 80(3):421-6. PubMed ID: 9313661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.